Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes

[1]  J. McFadden,et al.  Uptake and Release of Double‐Walled Carbon Nanotubes by Mammalian Cells , 2010 .

[2]  Emmanuel Flahaut,et al.  Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments. , 2010, ACS nano.

[3]  M. Prato,et al.  Two-dimensional diffusion-ordered NMR spectroscopy as a tool for monitoring functionalized carbon nanotube purification and composition. , 2010, ACS nano.

[4]  Liang Zhao,et al.  P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. , 2010, ACS nano.

[5]  Jianlin Shi,et al.  The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.

[6]  Bing Yan,et al.  Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. , 2009, Nano letters.

[7]  Xiaoke Zhang,et al.  Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. , 2009, Biomaterials.

[8]  Zhuang Liu,et al.  Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. , 2009, Angewandte Chemie.

[9]  J. McFadden,et al.  Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy , 2009 .

[10]  C. Tîlmaciu,et al.  AFM imaging of functionalized double-walled carbon nanotubes. , 2009, Ultramicroscopy.

[11]  Z. Luan,et al.  Aqueous stability of oxidized carbon nanotubes and the precipitation by salts. , 2009, Journal of hazardous materials.

[12]  H. Dai,et al.  PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. , 2009, Journal of the American Chemical Society.

[13]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[14]  Maurizio Prato,et al.  Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. , 2008, Chemical communications.

[15]  Hongjie Dai,et al.  Supramolecular Chemistry on Water- Soluble Carbon Nanotubes for Drug Loading and Delivery , 2007 .

[16]  M. Prato,et al.  Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. , 2007, Nature nanotechnology.

[17]  R. Verdejo,et al.  Removal of oxidation debris from multi-walled carbon nanotubes. , 2007, Chemical communications.

[18]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[19]  D. Nowotnik,et al.  Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. , 2004, Journal of inorganic biochemistry.

[20]  Philip S Low,et al.  Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. , 2004, Advanced drug delivery reviews.

[21]  R. Gillies,et al.  Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. , 2003, Biochemical pharmacology.

[22]  Ya‐Ping Sun,et al.  Solubilization of Single-Walled Carbon Nanotubes with Diamine-Terminated Oligomeric Poly(ethylene Glycol) in Different Functionalization Reactions , 2003 .

[23]  J. Beijnen,et al.  Aspects of the degradation kinetics of doxorubicin in aqueous solution , 1986 .

[24]  J. Beijnen,et al.  Anthracycline antitumour agents , 1986, Pharmaceutisch Weekblad.

[25]  T. Tritton,et al.  PHOTOINACTIVATION OF ANTHRACYCLINES * , 1981 .

[26]  S. Siegel,et al.  Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. , 1976, Cancer research.

[27]  V. Neves.  Carbon nanotubes (CNT) : feasibility as nano-bio agents to target cancer , 2010 .

[28]  J. Beijnen,et al.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties , 2005, Pharmaceutisch Weekblad.

[29]  Da-peng Wang,et al.  Stability of Mixtoxantrone Hydrochloride in Solution , 1994 .

[30]  M. Green,et al.  Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. , 1992, Cancer research.